may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
.
updated: may 18, 2018, 10.36 am ist
. is the place to come for breaking news, analysis and for stories that are just too interesting � or too entertaining � to pass up.
.
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment.
. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire.
.
.